Henry Hsu, M.D., Chief Medical Officer, CoMentis, a pharmaceutical company engaged in the discovery and development of small-molecule drugs to treat Alzheimer’s disease, age-related macular degeneration (AMD) and cognitive disorders. (more…)

August M. Watanabe, MD, joined Frazier Healthcare Ventures in 2005 as Senior Advisor to the Biopharma team.   (more…)

MedImmune Ventures, Inc. is a wholly owned venture capital subsidiary of MedImmune, Inc. It was created in 2002 to leverage the company’s expertise in discovering, developing and commercializing biotechnology products, as well as its financial resources, to transform new ideas in biotechnology into successful products and companies. (more…)

Joe Amprey is a member of the Metastatix Board of Directors and is also a Principal at MedImmune Ventures. (more…)

Drew Senyei, MD, is a managing director at Enterprise Partners  where he leads the life science practice. Drew focuses on investments in pharmaceuticals, biopharmaceuticals, diagnostics, medical devices and consumer healthcare. (more…)

Dr. Hanson’s book The Joy of Stress has sold over a million copies in twenty languages, followed by his other bestsellers, Stress for Success and Counterattack. (more…)

Dr. Barlow joined BrainCells, Inc. (BCI), a biopharmaceutical company focused on the development of breakthrough small molecule therapeutics for diseases of the central nervous system (CNS), in August 2004. She is the Chief Scientific Officer of the company.

(more…)

Today I attended an interesting lecture at Jefferson Medical College sponsored by the Department of Health Policy. John O. Agwunobi, M.D., M.B.A., M.P.H., Senior Vice President, and President, Health and Wellness, Wal-Mart Stores Division, and former Assistant Secretary for Health, U.S. Department of Health and Human Services, gave the 17th Annual Dr. Raymond C. Grandon Lecture, “Bridging the Worlds of Business and Public Health.” (more…)

CoMentis is a biotech company focused on the research and development of small molecule drugs to treat neurovascular diseases such as Alzheimer’s disease (AD), age-related macular degeneration (AMD) and other cognitive disorders. (more…)

W. Scott Harkonen, MD, is President and Chief Executive Officer of CoMentis, a biotechnology company. (more…)